Abstract: Technologies are provided for tracking learning progress of an end user of a cloud computing platform when the end user is not registered with an external learning platform that provides an external learning application. In response to the end user interacting with virtual learning entities provided at the cloud computing platform, learning progress information with respect to the external learning application is generated. The interaction by the end user takes place in the context of an application provided by the cloud computing platform while in an active web session. The virtual learning entities represent content of the external learning application (e.g., learning content and contextual user information of the external learning application). When a user service of the external learning platform receives a request to persist the learning progress information for the end user, the user service can determine whether a corresponding user account (e.g.

Abstract: Technologies are provided for integrating learning data provided by an external learning platform (ELP) to create a custom learner experience within a context of an application provided by a cloud computing platform (CCP). The system can include the CCP, the ELP, learner APIs that expose a common learning data schema on the CCP, and a user interface platform (UIP). The UIP can include a compiler that transforms source code of UICs of a componentized learner user interface for usage on the CCP, and a bundler that generates a package of UI components (UICs) that are compatible for usage on the CCP. The UICs are specific to the learning data schema shared with the learner APIs. The UIP exports the package to the CCP, which composes the learning data provided via learner APIs and UICs from the package to provide the custom learner experience within the context of the application.

Abstract: A method of processing media output events, each having a corresponding duration, from a plurality of media content receivers within a media distribution system, comprises: a. dividing the output events into a plurality of segments, such that output events having similar properties are placed into the same one of said segments; b. within each said segment, identifying a long duration threshold based on the distribution of the durations of the output events within that segment; c. and applying the long duration thresholds of each said segment for control and/or analysis of the media distribution system.

Abstract: GLP-2 analogs are disclosed which comprise one of more substitutions as compared to h[Gly2]GLP-2 and which may have the property of an altered GLP-1 activity, and their medical use. The analogs are particularly useful for the prophylaxis treatment or ameliorating of the gastro-intestinal associated side effects of diabetes.

Abstract: GLP-2 analogues are disclosed which comprise one of more substitutions as compared to h[Gly2]GLP-2 and which may have the property of an altered GLP-1 activity, and their medical use. The analogues are particularly useful for the prophylaxis treatment or ameliorating of the gastro-intestinal associated side effects of diabetes.

Abstract: GLP-2 analogs are disclosed which comprise one of more substitutions as compared to h[Gly2]GLP-2 and which may have the property of an altered GLP-1 activity, and their medical use. The analogs are particularly useful for the prophylaxis treatment or ameliorating of the gastro-intestinal associated side effects of diabetes.

Abstract: A method of processing media output events, each having a corresponding duration, from a plurality of media content receivers within a media distribution system, comprises: a. dividing the output events into a plurality of segments, such that output events having similar properties are placed into the same one of said segments; b. within each said segment, identifying a long duration threshold based on the distribution of the durations of the output events within that segment; c. and applying the long duration thresholds of each said segment for control and/or analysis of the media distribution system.

Abstract: GLP-2 analogues are disclosed which comprise one of more substitutions as compared to h[Gly2]GLP-2 and which may have the property of an altered GLP-1 activity, and their medical use. The analogues are particularly useful for the prophylaxis treatment or ameliorating of the gastro-intestinal associated side effects of diabetes.

Abstract: GLP-2 analogs are disclosed which comprise one of more substitutions as compared to h[Gly2]GLP-2 and which may have the property of an altered GLP-1 activity, and their medical use. The analogs are particularly useful for the prophylaxis, treatment or ameliorating of the gastro-intestinal associated side effects of diabetes.

Abstract: GLP-2 analogues are disclosed which comprise one of more substitutions as compared to h[Gly2]GLP-2 and which may have the property of an altered GLP-1 activity, and their medical use. The analogues are particularly useful for the prophylaxis, treatment or ameliorating of the gastro-intestinal associated side effects of diabetes.